Archive for the ‘Prostate / Prostate Cancer’ Category

Blocking The Effect Of Inflammation-Causing Cells Lowered Prostate Cancer Cells Invasion

Thursday, April 10th, 2008

Recent studies have suggested an association between chronic inflammation and cancers of the prostate, colon, stomach and liver. Now scientists at Northwestern University Feinberg School of Medicine report success in blocking an early step in metastasis of prostate cancer cells by interrupting the communication between the cancer cells and other ...

Prostate Cancer DNA Vaccine Results In Higher T-Cell Response When Delivered Via Inovio Biomedical’s Electroporation Delivery System

Monday, April 7th, 2008

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced that the team of Dr. Christian H. Ottensmeier, MD, PhD, Cancer Research UK Senior Clinical Research Fellow at the University of Southampton, will present interim data from a clinical study of an ...

New Clues To Genetics Of Type 2 Diabetes Offered By Major International Collaboration

Tuesday, April 1st, 2008

An international collaboration of scientists from Europe and the US has identified six new genes which play a role in the development of type 2 diabetes, extending the total number of genes implicated in common forms of the disease to sixteen.The findings provide valuable new insights into the mechanisms responsible ...

A Nomogram Predicting 10-Year Life Expectancy In Candidates For Radical Prostatectomy Or Radiotherapy For Prostate Cancer

Monday, March 31st, 2008

UroToday.com - Family Physicians Could Help in Predicting Life Expectancy without Prostate Cancer. In the online version of the Journal of Clinical Oncology, Dr. Ravinder Mohan, Department of Family and Community Medicine, Eastern Virginia Medical School has published an interesting correspondence regarding the role for primary care physicians in determining ...

New Tool For Prostate Cancer Diagnosis

Thursday, March 20th, 2008

New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology1 support the use of PROGENSA PCA3 as a tool for diagnosing prostate cancer. The study confirms that PROGENSA PCA3, the world's first gene-based urine test to help detect prostate cancer, can provide clinicians with ...

Nymox Releases Further Results From Latest U.S. Study Of NX-1207 For Benign Prostatic Hyperplasia

Thursday, March 13th, 2008

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced that results from the Company's new multi-center U.S. Phase 2 study showed evidence that the Company's proprietary drug NX-1207 can markedly reduce the incidence of nighttime urination (nocturia), a particularly bothersome symptom associated with benign prostatic hyperplasia (BPH). After 90 days, subjects treated with ...

Chronic Kidney Disease - Europe’s Silent Epidemic

Wednesday, March 5th, 2008

The European Kidney Health Alliance (EKHA) and World Kidney Day organisations call for European health polices to support early identification and treatment of chronic kidney disease (CKD). The meeting, held in the European Parliament, marks the occasion of World Kidney Day, which this year will be on 13th March. An ...

New Blood Marker May Predict Prostate Cancer Spread

Thursday, February 28th, 2008

Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. Their study is published in the March 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. When cancer ...

IRIS International Announces Successful Completion Of Retrospective Study Of 85 Post-Prostatectomy Patients Using Its Investigational NADiA PSA Assay

Thursday, February 28th, 2008

Iris International, Inc. (NASDAQ GM: IRIS) announced that its Iris Molecular Diagnostics (IMD) group has successfully completed a retrospective study of stored leftover serum of 85 post-prostatectomy patients, men who had their prostate removed due to prostate cancer, using its investigational NADiA™ (Nucleic Acid Detection ImmunoAssay) PSA Assay. In ...

ASCO GU 2008 - RTOG Genitourinary Radiation Oncology Specialists Reach Consensus On Pelvic Lymph Node Volumes For High Risk Prostate Cancer

Wednesday, February 27th, 2008

UroToday.com - Dr. Lawton discussed the role for pelvic LN XRT in CaP. A survey performed at leading radiotherapy centers revealed that there was not consistent opinion on what pelvic XRT entailed. A meeting in 2007 reviewed the existing data on prostate nodal drainage and it appears that pre-sacral LNs ...